Johnson & Johnson Total Current Liabilities 2010-2024 | JNJ

Johnson & Johnson total current liabilities for the quarter ending September 30, 2024 were $51.759B, a 16.65% increase year-over-year.

  • Johnson & Johnson total current liabilities for 2023 were $46.282B, a 17.06% decline from 2022.
  • Johnson & Johnson total current liabilities for 2022 were $55.802B, a 23.38% increase from 2021.
  • Johnson & Johnson total current liabilities for 2021 were $45.226B, a 6.43% increase from 2020.

Johnson & Johnson Total Current Liabilities 2010-2024 | JNJ

  • Johnson & Johnson total current liabilities for 2023 were $46.282B, a 17.06% decline from 2022.
  • Johnson & Johnson total current liabilities for 2022 were $55.802B, a 23.38% increase from 2021.
  • Johnson & Johnson total current liabilities for 2021 were $45.226B, a 6.43% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B